US Patent Issued to SHIONOGI & Co. on Oct. 6 for "Formulation for oral administration, comprising triazine derivative" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,955, issued on Oct. 6, was assigned to SHIONOGI & Co. LTD. (Osaka, Japan).

"Formulation for oral administration, comprising triazine derivative" was invented by Masato Gomi (Osaka, Japan), Kensuke Horiuchi (Osaka, Japan), Masayuki Morimoto (Osaka, Japan) and Keisuke Takagaki (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a formulation for oral administration, comprising a triazine derivative having virus proliferation inhibitory action."

The patent was filed on Nov. 22, 2022, under Application No. 18/277,445.

*For further information, including images, charts and tables, please visit: http://patft.uspto....